We speculated that metformin or deletion of the FOXA1 gene might contribute to a greater effect with a lower dose of tamoxifen in blocking hormone-receptor-positive breast cancer (HR+ BC) cell proliferation. This evidence concerns the gene NR4A1 and breast cancer.